Connection

Mitzi Nagarkatti to Disease Progression

This is a "connection" page, showing publications Mitzi Nagarkatti has written about Disease Progression.
Connection Strength

0.757
  1. The role of gut microbiota in shaping the relapse-remitting and chronic-progressive forms of multiple sclerosis in mouse models. Sci Rep. 2019 05 06; 9(1):6923.
    View in: PubMed
    Score: 0.507
  2. Inverse correlation of expression of microRNA-140-5p with progression of multiple sclerosis and differentiation of encephalitogenic T helper type 1 cells. Immunology. 2016 Apr; 147(4):488-98.
    View in: PubMed
    Score: 0.101
  3. MicroRNA let-7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis. Eur J Immunol. 2013 Jan; 43(1):104-14.
    View in: PubMed
    Score: 0.081
  4. Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells. Front Immunol. 2018; 9:1782.
    View in: PubMed
    Score: 0.030
  5. Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis. Toxicol Appl Pharmacol. 2012 Jan 15; 258(2):256-67.
    View in: PubMed
    Score: 0.019
  6. Role of resveratrol-induced CD11b(+) Gr-1(+) myeloid derived suppressor cells (MDSCs) in the reduction of CXCR3(+) T cells and amelioration of chronic colitis in IL-10(-/-) mice. Brain Behav Immun. 2012 Jan; 26(1):72-82.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.